Related Experiment Video
Updated: May 7, 2026

Treatment with Vancomycin Loaded Calcium Sulphate and Autogenous Bone in an Improved Rabbit Model of Bone Infection
Published on: March 14, 2019
Recent lessons for the management of bone and joint infections
1Section of Pediatric Infectious Diseases, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA; Infectious Disease Service, Texas Children's Hospital, Feigin Center, Suite 1150, 1102 Bates Ave., Houston, TX 77030, USA.
Abstract:
The epidemiology and clinical manifestations of osteoarticular infections are changing primarily as a result of the emergence of community-acquired methicillin-resistant Staphylococcus aureus infections. Multifocal disease, venous thrombosis and pathologic fractures are manifestations of CA-MRSA osteomyelitis. MRI is the diagnostic imaging modality of choice for musculoskeletal infections. Nafcillin/oxacillin or cefazolin remains the antibiotic of choice for treating infections caused by MSSA. A β-lactam antibiotic is recommended for Kingella kingae. Vancomycin and clindamycin are the first line agents for treating osteomyelitis caused by CA-MRSA. A short course of parenteral antibiotics followed by appropriate oral antibiotics is equivalent to total course of parenteral antibiotics for most patients and avoids the risks associated with PICCs. Surgical drainage of subperiosteal abscesses and surrounding pyomyositis is common with S. aureus clones currently circulating. Collaboration with hematologists for managing patients with venous thromboses is recommended.
Insights
Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) is changing osteoarticular infections, leading to multifocal disease and fractures. Treatment involves specific antibiotics like vancomycin for CA-MRSA and MRI for diagnosis.
Area of Science:
- Infectious Diseases
- Orthopedic Surgery
- Radiology
Background:
- Osteoarticular infections are evolving due to the rise of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA).
- CA-MRSA osteomyelitis presents with unique manifestations including multifocal disease, venous thrombosis, and pathologic fractures.
- Current treatment guidelines and diagnostic approaches require updates to address these changes.
Purpose of the Study:
- To review the changing epidemiology and clinical features of osteoarticular infections.
- To highlight the diagnostic role of MRI in musculoskeletal infections.
- To outline current and recommended therapeutic strategies for various causative pathogens, including CA-MRSA.
Main Methods:
- Literature review of recent studies on osteoarticular infections.
- Analysis of clinical manifestations and diagnostic imaging findings.
- Evaluation of antibiotic treatment protocols and surgical interventions.
Main Results:
- CA-MRSA is a significant driver of changing osteoarticular infection patterns.
- MRI is the preferred imaging modality for diagnosing musculoskeletal infections.
- Effective antibiotic choices include nafcillin/oxacillin or cefazolin for MSSA, beta-lactams for Kingella kingae, and vancomycin/clindamycin for CA-MRSA.
- Short courses of parenteral antibiotics followed by oral antibiotics are effective.
- Surgical drainage is frequently required for S. aureus infections.
- Collaboration with hematology is recommended for managing associated venous thromboses.
Conclusions:
- The emergence of CA-MRSA necessitates updated approaches to diagnosing and managing osteoarticular infections.
- Tailored antibiotic therapy and timely surgical intervention are crucial for favorable outcomes.
- Multidisciplinary collaboration improves patient care for complex cases.
Related Concept Videos
Tonsillitis II: Management
Acute Pyelonephritis II: Diagnostic Studies and Management
Urinary Tract Infection IV: Nursing Management
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management

